Pfizer gets nod to market Migraine drug
Pfizer Inc said that it received approval from the Food and Drug Administration to market its Relpax migraine drug. Pfizer said Relpax is the newest product in a class of antimigraine medicines
Pfizer Inc said that it received approval from the Food and Drug Administration to market its Relpax migraine drug. Pfizer said Relpax is the newest product in a class of antimigraine medicines